The Role of Chromogranin A as a Predictor of Radiological Disease Progression in Midgut and Pancreatic Neuroendocrine Tumors

被引：0
|
作者：
Rossi, R. E. [1 ]
Garcia-Hernandez, J. [1 ]
Martin, N. G. [2 ]
Mohmaduves, M. [1 ]
Meyer, T. [3 ]
Thirlwell, C. [3 ]
Watkins, J. [4 ]
Caplin, M. [1 ]
Toumpanakis, C. [1 ]
机构：
[1] Royal Free Hosp, Ctr Gastroenterol, Neuroendocrine Tumour Unit, London NW3 2QG, England
[2] Royal Free Hosp, Dept Clin Biochem, London, England
[3] UCL, Inst Canc, London, England
[4] Royal Free Hosp, Dept Histopathol, London NW3 2QG, England
来源：
NEUROENDOCRINOLOGY | 2014年 / 99卷 / 3-4期
关键词：
chromogranin a; neuroendocrine tumors; radiological progression;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H18
引用
收藏
页码：257 / 258
页数：2
相关论文
共 50 条
  • [1] Chromogranin a As a Predictor of Radiological Disease Progression in Neuroendocrine Tumors
    Rossi, Roberta E.
    Garcia-Hernandez, Jorge
    Martin, Nick
    Meyer, Tim
    Thirlwell, Christina
    Watkins, Jennifer
    Caplin, Martyn
    Toumpanakis, Christos
    [J]. GASTROENTEROLOGY, 2014, 146 (05) : S333 - S333
  • [2] Chromogranin A as a predictor of radiological disease progression in neuroendocrine tumours
    Rossi, Roberta Elisa
    Garcia-Hernandez, Jorge
    Meyer, Tim
    Thirlwell, Christina
    Watkins, Jennifer
    Martin, Nicholas Guy
    Caplin, Martyn Evan
    Toumpanakis, Christos
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (09)
  • [3] ROLE OF CHROMOGRANIN A(CGA) IN PANCREATIC NEUROENDOCRINE TUMORS
    Nayak, Asha
    Johnson, Burles
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 61 - 61
  • [4] Chromogranin A as a Predictor of Progression, Regression or Stable Disease in Ileo-Cecal (midgut) Carcinoid Tumors
    Mynster, T.
    Jensen, K. H.
    Hilsted, L.
    Knigge, U.
    [J]. NEUROENDOCRINOLOGY, 2010, 92 (01) : 48 - 48
  • [5] Chromogranin A as a Predictor of Progression, Regression or Stable Disease in Ileo-Cecal Neuroendocrine Tumors
    Jensen, K.
    Hilsted, L.
    Jensen, C.
    Mynster, T.
    Knigge, U.
    [J]. NEUROENDOCRINOLOGY, 2011, 94 : 6 - 6
  • [6] Age is an independent Predictor of Chromogranin A Levels in Patients with pancreatic neuroendocrine Tumors
    Overheu, O.
    Gisder, D. M.
    Nopel-Dunnebacke, S.
    Janot, M.
    Uhl, W.
    Tannapfel, A.
    Reinacher-Schick, A.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 155 - 155
  • [7] Plasma Chromogranin B as a Marker of Tumor Burden and Radiological Progression in Neuroendocrine Tumors
    Braude, D.
    Bartholomew, T. K.
    Rossi, R. E.
    Garcia-Hernandez, A.
    Mullan, M.
    Caplin, M.
    Toumpanakis, C.
    [J]. NEUROENDOCRINOLOGY, 2014, 99 (3-4) : 252 - 252
  • [8] Prospective Study of Chromogranin A as a Predictor of Progression in Patients with Pancreatic, Small-Intestinal, and Unknown Primary Neuroendocrine Tumors
    Dam, Gitte
    Gronbaek, Henning
    Sorbye, Halfdan
    Evensen, Espen Thiis
    Paulsson, Bjorn
    Sundin, Anders
    Jensen, Claus
    Ebbesen, Dyveke
    Knigge, Ulrich
    Janson, Eva Tiensuu
    [J]. NEUROENDOCRINOLOGY, 2020, 110 (3-4) : 217 - 224
  • [9] Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumors
    Pulvirenti, Alessandra
    Rao, Deepthi
    Mcintyre, Caitlin A.
    Gonen, Mithat
    Tang, Laura H.
    Klimstra, David S.
    Fleisher, Martin
    Ramanathan, Lakshmi V.
    Reidy-Lagunes, Diane
    Allen, Peter J.
    [J]. HPB, 2019, 21 (05) : 612 - 618
  • [10] Chromogranin A and NSE in cystic pancreatic neuroendocrine tumors
    Faias, Sandra
    Prazeres, Susana
    Cunha, Mario
    Pereira, Luisa
    Roque, Ruben
    Chaves, Paula
    Cravo, Marilia
    Claro, Isabe
    Silveira, Margarida
    Leite, Valeriano
    Pereira, Dias
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (04)
12345